188 related articles for article (PubMed ID: 27466992)
1. GAS5 is downregulated in gastric cancer cells by promoter hypermethylation and regulates adriamycin sensitivity.
Zhang N; Wang AY; Wang XK; Sun XM; Xue HZ
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3199-205. PubMed ID: 27466992
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
4. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of tescalcin by modification of promoter methylation controls cell survival in gastric cancer cells.
Kim TW; Han SR; Kim JT; Yoo SM; Lee MS; Lee SH; Kang YH; Lee HG
Oncol Rep; 2019 Jun; 41(6):3464-3474. PubMed ID: 31002343
[TBL] [Abstract][Full Text] [Related]
7. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
8. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
[TBL] [Abstract][Full Text] [Related]
9. Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.
Chen X; Cao X; Dong W; Xia M; Luo S; Fan Q; Xie J
Biochem Biophys Res Commun; 2010 Jan; 391(1):1070-4. PubMed ID: 20004178
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer.
Liu X; Lam EK; Wang X; Zhang J; Cheng YY; Lam YW; Ng EK; Yu J; Chan FK; Jin H; Sung JJ
Tumour Biol; 2009; 30(5-6):242-8. PubMed ID: 19816091
[TBL] [Abstract][Full Text] [Related]
11. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.
Cheng YY; Jin H; Liu X; Siu JM; Wong YP; Ng EK; Yu J; Leung WK; Sung JJ; Chan FK
Br J Cancer; 2008 Dec; 99(12):2083-7. PubMed ID: 18985039
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
13. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer.
Kim M; Jang HR; Haam K; Kang TW; Kim JH; Kim SY; Noh SM; Song KS; Cho JS; Jeong HY; Kim JC; Yoo HS; Kim YS
Carcinogenesis; 2010 Sep; 31(9):1685-93. PubMed ID: 20627872
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
15. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma.
Guo X; Liu W; Pan Y; Ni P; Ji J; Guo L; Zhang J; Wu J; Jiang J; Chen X; Cai Q; Li J; Zhang J; Gu Q; Liu B; Zhu Z; Yu Y
Oncogene; 2010 Jul; 29(27):3908-20. PubMed ID: 20440264
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of VEZT gene expression in human gastric cancer involves promoter methylation and miR-43c.
Guo X; Jing C; Li L; Zhang L; Shi Y; Wang J; Liu J; Li C
Biochem Biophys Res Commun; 2011 Jan; 404(2):622-7. PubMed ID: 21156161
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.
Ye Q; Shen Y; Wang X; Yang J; Miao F; Shen C; Zhang J
Tissue Antigens; 2010 Jan; 75(1):30-9. PubMed ID: 19883394
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells.
Xu L; Wang F; Xu XF; Mo WH; Xia YJ; Wan R; Wang XP; Guo CY
Med Oncol; 2011 Dec; 28 Suppl 1():S189-96. PubMed ID: 21053104
[TBL] [Abstract][Full Text] [Related]
19. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
